Form 8-K - Current report:
SEC Accession No. 0000950170-25-031995
Filing Date
2025-03-04
Accepted
2025-03-04 16:08:34
Documents
17
Period of Report
2025-03-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tkno-20250304.htm   iXBRL 8-K 54618
2 EX-10.1 tkno-ex10_1.htm EX-10.1 1192909
3 EX-10.2 tkno-ex10_2.htm EX-10.2 1234720
4 EX-99.1 tkno-ex99_1.htm EX-99.1 683457
5 GRAPHIC img14554028_0.jpg GRAPHIC 22644
6 GRAPHIC img15477549_0.jpg GRAPHIC 22644
7 GRAPHIC img201297901_0.jpg GRAPHIC 375444
  Complete submission text file 0000950170-25-031995.txt   4247717

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT tkno-20250304.xsd EX-101.SCH 25989
19 EXTRACTED XBRL INSTANCE DOCUMENT tkno-20250304_htm.xml XML 4913
Mailing Address 2451 BERT DRIVE HOLLISTER CA 95023
Business Address 2451 BERT DRIVE HOLLISTER CA 95023 8316371100
Alpha Teknova, Inc. (Filer) CIK: 0001850902 (see all company filings)

EIN.: 943368109 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40538 | Film No.: 25704347
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)